Development of a CTL Epitope-Based Vaccine Targeting Tumor Antigens in Esophageal Cancer: An Immunoinformatic Study.

The vaccine demonstrates strong potential as a safe, stable, and broadly applicable immunotherapeutic candidate against esophageal cancer, pending experimental validation.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-10-01
DOI
https://doi.org/10.30498/ijb.2025.509383.4084
Primary Topic
vaccines and immunoinformatics approaches
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of a CTL Epitope-Based Vaccine Targeting Tumor Antigens in Esophageal Cancer: An Immunoinformatic Study.

Hongyou Cao, Fengjiao Ding
PubMed
vaccines and immunoinformatics approaches
article

Development of a CTL Epitope-Based Vaccine Targeting Tumor Antigens in Esophageal Cancer: An Immunoinformatic Study.

Hongyou Cao, Fengjiao Ding
article en

Abstract

The vaccine demonstrates strong potential as a safe, stable, and broadly applicable immunotherapeutic candidate against esophageal cancer, pending experimental validation.

PubMedVol. 23(4)
Ankang City Central Hospital (CN)
Openalex Percentile: Top 68%
vaccines and immunoinformatics approaches
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of a CTL Epitope-Based Vaccine Targeting Tumor Antigens in Esophageal Cancer: An Immunoinformatic Study. — Hongyou Cao, Fengjiao Ding · PubMed (2025) | TGRS Research Map | TGRS